The Immunology of Psoriasis-Current Concepts in Pathogenesis
Open accessThe DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Abstract
Psoriasis is one of the most common inflammatory skin diseases with a chronic, relapsing-remitting course. The last decades of intense research uncovered a pathological network of interactions between immune cells and other types of cells in the pathogenesis of psoriasis. Emerging evidence indicates that dendritic cells, T H 17 cells, and keratinocytes constitute a pathogenic triad in psoriasis. Dendritic cells produce TNF-α and IL-23 to promote T cell differentiation toward T H 17 cells that produce key psoriatic cytokines IL-17, IFN-γ, and IL-22. Their activity results in skin inflammation and activation and hyperproliferation of keratinocytes. In addition, other cells and signaling pathways are implicated in the pathogenesis of psoriasis, including T H 9 cells, T H 22 cells, CD8 + cytotoxic cells, neutrophils, γδ T cells, and cytokines and chemokines secreted by them. New insights from high-throughput analysis of lesional skin identified novel signaling pathways and cell populations involved in the pathogenesis. These studies not only expanded our knowledge about the mechanisms of immune response and the pathogenesis of psoriasis but also resulted in a revolution in the clinical management of patients with psoriasis. Thus, understanding the mechanisms of immune response in psoriatic inflammation is crucial for further studies, the development of novel therapeutic strategies, and the clinical management of psoriasis patients. The aim of the review was to comprehensively present the dysregulation of immune response in psoriasis with an emphasis on recent findings. Here, we described the role of immune cells, including T cells, B cells, dendritic cells, neutrophils, monocytes, mast cells, and innate lymphoid cells (ILCs), as well as non-immune cells, including keratinocytes, fibroblasts, endothelial cells, and platelets in the initiation, development, and progression of psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most frequent and important findings are represented by the psoriasiform pattern associated with confluent parakeratosis and chronic dermal inflammation.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dilated and tortuous capillaries are frequently present in the papillary dermis and correspond clinically to the Auspitz phenomenon [20].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The disease is characterized by hyperproliferation of the epidermis, with a high epidermal turnover rate and scale formation.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neutrophilic collections represent important diagnostic clues.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fully developed plaques typically demonstrate regular acanthosis with elongated and relatively uniform rete ridges, thinning of the suprapapillary plates, confluent parakeratosis, and reduction or absence of the granular layer.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measured
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 2×
“However, IL-17 is also implicated in a variety of T H 17-mediated inflammatory autoimmune diseases [113, 114].”
BackgroundIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review
Armstrong, A. W., & Read, C. (2020) · JAMA · doi:10.1001/jama.2020.4006 · Cited by 2,335
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 2×
“It was demonstrated that IL-17 and IL-22 can be co-expressed by T H 17 cells and synergize in the induction of the expression of AMPs by KCs in vitro [208].”
BackgroundPsoriasis Pathogenesis and Treatment
Rendon, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,064
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 3×
“Complexes consisting of DNA or RNA and LL37 are abundant in lesional skin [19, 106].”
BackgroundInterleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862 · cited 1×
“IL-22 produced by T H 22 cells mediates acanthosis and immune cell infiltration induced by IL-23 [69].”
BackgroundAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847 · cited 3×
“T H 17 cells are activated by factors that are upregulated in the psoriatic milieu, including IL-23, as well as IL-21 in an autocrine manner [68, 74].”
Background
Cited by
Items 301–346 of 346
Su, K., Zang, Y., Liu, S., Wen, J., Zhao, X., Jiang, A., He, Y., & Wei, L. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117250
Wu, X., He, M., Chen, H., & Gan, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1903929
Skowrońska, W., Kiełkiewicz, R. M., Kirzyc, M., Janowski, M., Kołodziejska, J., Michorowska, S., Dawidowski, M., Kolmas, J., Giebułtowicz, J., Granica, S., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119845
Sphingosine-1-Phosphate Signaling and Nanocarrier-Based Topical Therapeutics in Plaque Psoriasis
Mohan, V. K., & Kaliyaperumal, R. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10903-5
“Consequently, chronic skin inflammation and increased keratinocyte production occur [5].”
Hashimoto, R., Wu, Y., Fujimoto, K., Shintani, H., Koide, H., & Katoh, Y. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.105013
Inhibition of salt-inducible kinases 2 and 3 reduces inflammatory signature in psoriasis
Pilz, A. C., Briem, E., Colli, M. L., Hillig, C., Lavazais, S., Menden, M. P., Biedermann, T., Lauffer, F., Eyerich, K., Vos, S. D., et al. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2026.07.033
Potential effects of metformin on psoriasis management: evidence from cells to bedside
Rutnumnoi, T., Chattipakorn, N., & Chattipakorn, S. C. (2026) · Archives of Dermatological Research · doi:10.1007/s00403-026-04822-1
“These, in turn, activate Toll-like receptors (TLRs) in keratinocytes and dendritic cells, thereby initiating inflammation in lesional skin [ 75].”
Li, X., Ding, Z., Huang, Z., Ma, Y., Xiao, Y., Pei, B., Liu, X., Shen, Y., He, Y., Su, Y., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103584
“…skin diseases dominated by the IL-17/IL-23 axis, such as psoriasis, IL-17 and IL-22 can indirectly maintain a nerve-stimulating microenvironment by inducing keratinocytes to release chemokines, antimicrobial peptides, and inflammatory mediators, thereby influencing itch and pain sensitivity [71].”
Guo, Y., Yang, J., Xiao, M., Zhang, Z., Ma, K., Fu, X., & Yang, S. (2026) · Health Science Reports · doi:10.1002/hsr2.73095
“Psoriasis is a skin disease caused by an immune system disorder and is prevalent worldwide [23, 24].”
Yang, Y., Guo, D., Chen, W., Sun, B., Qiu, M., Wang, K., Dou, W., Wang, K., Zhang, Z., & Feng, S. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091085
“Cytokine and chemokine pathways are closely associated with inflammatory-cell recruitment in psoriatic lesions [5,6,8], whereas IL-17 signaling promotes keratinocyte activation, inflammatory mediator production and epidermal hyperplasia [5–7].”
Nanocarrier-based Herbal Topical Delivery Systems: Recent Progress in Psoriasis Treatment
Roy, P. S., & Sharma, D. K. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00629-8
Cho, M. K., Choi, M., Kim, K. D., Park, S. Q., Lee, S.-H., Nam, H.-S., & Lee, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177877
Feng, X., Chen, Y., Fu, P., Wang, B., Li, J., & Li, X. (2026) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-026-00333-8
Neural regulatory networks: challenges and opportunities in the treatment of psoriasis
Guo, D., Xi, R., Huang, T., Yuan, S., Lu, H., Wang, Y., Zhu, J., Guo, W., Liu, X., & Li, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1942535
“Additionally, genetic predispositions, together with environmental factors such as infections, stress, and certain medications, has been demonstrated to trigger or exacerbate the condition (3, 7, 8).”
Xin, W., Tian, Y., Wang, S., Zhang, S., & Chen, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1902354
“Th22-derived IL-22, as an important downstream effector arm of IL-23-driven in fl ammatory responses, mediates IL-23-induced acanthosis and immune cell in fi ltration and contributes to cutaneous tissue re-modeling and sustained in fl ammation (52).”
InfluentialDefensins mediate skin inflammation and itch in psoriasis
Balaji, S. K., Zheng, Q., Yu, H., Truong, J., Fernando, L. G. B., Liu, Y., Shin, C., Luo, W., Dong, X., & Dong, X. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2026.08.014
“…psoriasis. qPCR analysis revealed that IMQ-treated Def cKO skin exhibited a marked reduction in the expression of neutrophil-associated genes, including Il1b, Cxcl2, Tnf, S100a8, and S100a9, compared with IMQ-treated WT skin (Figure 3a) (Man et al. 2023; Sato et al. 2020; Sieminska et al. 2024).”
Gao, S., Yin, R., Shi, J., Miao, Z., Yang, L., & Zhao, D. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100660
“Psoriasis is a chronic immune-mediated inflammatory skin disease characterized by excessive keratinocyte proliferation and persistent immune activation (Sieminska et al., 2024).”
Shen, J., Song, L., Ye, Z., Jiang, M., & Liu, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14092048
“Psoriasis is a chronic, immune-related skin disease characterized by hyperproliferation of keratinocytes and cutaneous infiltration of immune cells including neutrophils, lymphocytes and monocytes, leading to circumscribed, scaling and erythematous plaques [1].”
Barhoon, M., Mahdiuni, H., Ebrahimi, A., & Khodarahmi, R. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02364-6
MODERN CONCEPTS OF THE ROLE OF CYTOKINES IN THE DYSREGULATION OF THE IMMUNE SYSTEM IN PSORIASIS
Літус, І. О. (2026) · The Medical and Ecological Problems · doi:10.31718/mep.2026.30.2.07
Savu, A.-P., Olteanu, R., Ciuc, D. M., Tiron, M.-A., Constantin, T. V., Mutu, C.-C., Bucur, Ș., & Constantin, M. M. (2026) · Life · doi:10.3390/life16091542
“Current evidence supports the pathogenic triad of dendritic cells, Th17 cells, and keratinocytes, in which the IL-23/Th17 axis plays a central role in the persistence of psoriatic inflammation [23].”
金祖汉, Huang, Z., Zhang, Y., Meng, M., Hong, L., & Li, M. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118477
Al-Sawahli, M. M., Al-Zurfi, A. M. J., Ameen, A. A. H., Abdallah, A. N., Alamoudi, J. A., Saleh, A., El‐Telbany, R. F. A., Salahuddin, A., Alfaifi, M. Y., Shati, A. A., et al. (2026) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2026.103025
TRPV1 channels in skin homeostasis and disease: From sensory transduction to therapeutic targeting
Song, F., Xiang, Y., Nie, H., Yin, Y., Guan, Y., Zhu, W., & Liu, L. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117447
Gomes, G. S., Rosales, T. K. O., Facchini, J. C., Frank, L. A., Longhi, M. S., & Santos, H. A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115357
Thorajak, P., Junlatat, J., Srisongkram, T., & Tuntiyasawasdikul, S. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122428
Shadman, M., Hashmi, A. R., Zahra, F., Ravi, R. N., Jaganathan, R., Wong, L. S., Mehta, J., Rai, P. S., Tamilanban, T., & Sekar, M. (2026) · Phytomedicine Plus · doi:10.1016/j.phyplu.2026.101047
Abd, W. S. (2026) · International Journal of Medical Parasitology and Epidemiology Sciences · doi:10.34172/ijmpes.6295
Gao, P., Zhou, X., Yeap, J.-W., Wang, C., Wang, J., Wang, Q., Wang, S., Liu, L., Sun, X., & Li, X. (2026) · JID Innovations · doi:10.1016/j.xjidi.2026.100544
Lee, J., Chun, Y. S., Nam, H. J., Huh, Y. J., Kim, J., Krueger, J. G., Paik, S. S., Kim, H. J., Jin, S., & Kim, J. (2026) · Allergy · doi:10.1111/all.70526
IL-17 in the prediction of the efficacy of biologic therapy for psoriasis
Arsenyeva, A. A., Еreshchenko, A. A., Lyamin, A. V., Migacheva, N. B., & Leontyeva, K. S. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-284
Chen, Q., 蔚林巍, Liu, Y., Li, Y., Jia, X., Li, Y., Wu, W., & Du, X. (2026) · Immunologic Research · doi:10.1007/s12026-026-09846-3 · Cited by 1
The active immune role of keratinocytes: from passive targets to key hubs in psoriatic inflammation
Pei, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1970701
“Modern studies con fi rm that psoriasis involves a complex interaction network among keratinocytes, dendritic cells (DCs), T lymphocytes, neutrophils, macrophages, natural killer (NK) cells, and mast cells (1, 3, 4).”
THE ROLE OF Fcγ-RECEPTORS IN THE BIOLOGICAL ACTION OF C-REACTIVE PROTEIN ON HUMAN MAST CELLS
Trulioff, A. S., Александровна, К. Н., & Kudryavtsev, I. V. (2026) · Advanced targets in Biomedicine · doi:10.5922/atb-2026-2-1-2
Beyond Systemic Burden: Periodontitis and Oral Health-Related Quality of Life in Psoriatic DiseasePreprint
POLAT, T., Daltaban, Ö., Kaçar, C., Alpsoy, E., & Üstün, K. (2026) · Research Square · doi:10.21203/rs.3.rs-10628587/v1
Alamri, A., Alzhrani, G., Sindi, M., Alharbi, A., Alsamadani, A., Alraddadi, R. A., Aldraibi, S., Fathi, A. B., Aljedani, H. A., Aljahdali, D., et al. (2026) · Cureus · doi:10.7759/cureus.117690
The role of emollients in the treatment of moderate and severe forms of psoriasis
Arsenyeva, A. A., Lyamin, A. V., Migacheva, N. B., Khaliulin, A. V., & Kalashnikova, A. N. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-366
Campelo, R. C., de Assunção, M. R. L., ROCHA, J. R., Santos, L. G. S., Lopes, É. S., Damianse, S. D. S. P., Azulay, R. S. D. S., Faria, M. D. S., Nascimento, G. C., & Rodrigues, V. P. (2026) · Pituitary · doi:10.1007/s11102-026-01767-6
Kamel, M. M., Zaki, H. F., Saleh, R. A., Henry, S. R., Ibrahim, M. K., Bakr, M. M., Abouhussein, D. M. N., & Rabie, M. A. (2026) · Pharmacia · doi:10.3897/pharmacia.73.e205623
“High-throughput analysis (Sieminska et al. 2024) and computational modeling have revealed that cytokines from DCs trigger Th cell differentiation into Th1, Th17, and Th22 subsets, disrupting skin homeostasis and amplifying inflammation through neutrophil activation.”
Fang, R., Zhou, Y., 葛棣, Pan, Y.-R., & Li, J.-H. (2026) · Archives of Dermatological Research · doi:10.1007/s00403-026-05009-4
Lin, Z., Lin, C.-Y., Chung, Y.-K., Alalaiwe, A. S., & Fang, J.-Y. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115474
Xiao, Y., Xiao, C., Li, Q., Dang, E., Zeng, B., Luo, M., & 唐雪勇 (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05231-8
Mitochondria as immunometabolic hubs in psoriasis: pathogenic mechanisms and therapeutic prospects
Zhao, F., Guo, Y., Tong, X., Zhou, X., Jiao, Y., Han, R., 陈洪铎, & Qi, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1991331
Ye, T., Mou, H., Qiu, W., & Li, Z. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215266
Th17 suppression strategies: targeting IL-17 and RORγt pathways in autoimmune diseases
Zian, Z., Aliyu, M., Hossain, F., Zohora, F. T., Ceylan, A., Moussa, N. B., Hsieh, W.-J., Abbes, F., Abubakar, S. D., & Azizi, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1941866
Gkornik, T., Toma, A. O., Levai, C. M., Caraba, A., & Borza, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219675
Metadata
- Authors
- Sieminska, I., Pieniawska, M., & Grzywa, T. M.
- Affiliations
- Institute of Human Genetics (PL)
- Children's Hospital of Philadelphia (US)
- Corresponding author
- Grzywa, Tomasz M.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2024-04-20
- Volume
- 66
- Issue
- 2
- Pages
- 164-191
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- PMC
- PMC11193704
- OpenAlex
- W4394989398
- Semantic Scholar
- 7834ce05fae760dae63e391276786d133a044e08
- Cited by
- 346
- References
- 308
- Citations by year
- 2026: 187 · 2025: 140 · 2024: 19
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Narodowe Centrum Nauki (2021/41/N/NZ6/02774)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- psoriasis, psoriasis pathogenesis, dendritic cells, Th17 cells, keratinocytes, IL-23, TNF-α, IL-17, IL-22, Th9 cells, Th22 cells, cytotoxic T lymphocytes, neutrophils, γδ T cells, innate lymphoid cells, mast cells, non-immune cells, skin inflammation, immune dysregulation
- MeSH terms
- Animals, Dendritic Cells, Humans, Psoriasis, Skin, Signal Transduction, Keratinocytes, T-Lymphocyte Subsets, Cytokines, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.